Selenium-binding protein 1 (SELENBP1) as biomarker for adverse clinical outcome after traumatic spinal cord injury

Traumatic spinal cord injury (TSCI) presents a diagnostic challenge as it may have dramatic consequences for the affected patient. Additional biomarkers are needed for improved care and personalized therapy.

Saved in:

Bibliographic Details
Main Authors:	Seelig, Julian (Author) , Heller, Raban (Author) , Haubruck, Patrick (Author) , Sun, Qian (Author) , Klingenberg, Georg Jochen (Author) , Hackler, Julian (Author) , Crowell, Helena Lucia (Author) , Daniel, Volker (Author) , Moghaddam-Alvandi, Arash (Author) , Schomburg, Lutz (Author) , Biglari, Bahram (Author)
Format:	Article (Journal)
Language:	English
Published:	28 May 2021
In:	Frontiers in neuroscience Year: 2021, Volume: 15, Pages: 1-13
ISSN:	1662-453X
DOI:	10.3389/fnins.2021.680240
Online Access:	Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.3389/fnins.2021.680240 Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/articles/10.3389/fnins.2021.680240
Author Notes:	Julian Seelig, Raban Arved Heller, Patrick Haubruck, Qian Sun, Georg Jochen Klingenberg, Julian Hackler, Helena Lucia Crowell, Volker Daniel, Arash Moghaddam, Lutz Schomburgn and Bahram Biglari

Description
Summary:	Traumatic spinal cord injury (TSCI) presents a diagnostic challenge as it may have dramatic consequences for the affected patient. Additional biomarkers are needed for improved care and personalized therapy.
Item Description:	Gesehen am 24.08.2022
Physical Description:	Online Resource
ISSN:	1662-453X
DOI:	10.3389/fnins.2021.680240